There’s big news happening at BioPlus Specialty Pharmacy: BioPlus will soon become part of Elevance Health (formerly Anthem, Inc.). As part of the Elevance Health family, BioPlus will bring its speed and innovation in specialty medication care to more patients than ever before.
Current BioPlus patients, as well as providers who refer to BioPlus, can rest easy knowing that the “fast & easy” experience they have come to count on with our specialty pharmacy will continue in 2023 and beyond.
We exist to make access to high-cost and life-saving treatments faster and easier for patients around the corner and around the world. That mission isn’t changing.
BioPlus has earned numerous awards and industry achievements for its “Power of 2” service — the world's first 2 hour, 2 day, 2 click, 2gether promise. Our one-of-a-kind “fast & easy” specialty pharmacy service will become available for millions of more patients across the country through our Elevance partnership.
Elevance serves 1 in 3 Americans through partnerships with health plans, its customers, government agencies, and care providers. 2gether, we will improve access and equity in specialty pharmacy care.
The transition from BioPlus as part of CarepathRx to Elevance Health will be complete early in 2023 after a standard process of regulatory review.
Related Posts
Patients Now Have ‘Fast and Easy’ Access to More Generic Oncology Medications
BioPlus Specialty Pharmacy today announces the expansion of its ‘Hope Delivered in 24 Hours’...
BioPlus Specialty Pharmacy Ensures Continuity of Care Ahead of Dorian
BioPlus Specialty Pharmacy, one of the nation’s leading innovative specialty pharmacies, passes...
Unlocking the Collaborative Power of Specialty Pharmacies: A Path to Healthier Lives
Patients with complex and chronic conditions deserve personalized, high-quality care that goes...
Meet Challenges and Find Solutions for Patients With Multiple Sclerosis by Partnering with the Right Specialty Pharmacy
BioPlus provides the best-in-class care your patients with MS deserve.
Access to a growing...